Canopy Growth (CGC) Revenue (2019 - 2026)
Canopy Growth (CGC) posted Revenue of $153.0 million for Q4 2025, up 215.75% sequentially from $48.5 million in Q3 2025, and up 185.88% YoY from $53.5 million in Q4 2024.
Canopy Growth (CGC) Revenue (2019 - 2026) Analysis & Trends
Canopy Growth has reported Revenue for 7 years, with the latest figure at $153.0 million in Q4 2025.
- Quarterly Revenue rose 185.88% year-over-year to $153.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $307.0 million (up 51.9% YoY) and the FY2026 annual result came in at $45.4 million, up 44.77% from the prior year.
- Revenue improved to $153.0 million in Q4 2025 per CGC's latest filing, from $48.5 million in the prior quarter.
- Over five years, Revenue peaked at $153.0 million in Q4 2025 and troughed at -$273.7 million in Q1 2022.
- A 5-year average of $58.6 million and a median of $57.7 million in 2023 frame the typical range for Revenue.
- The sharpest annual moves came in 2021 and 2022: Revenue soared 822.58% in 2021, then plunged 333.35% in 2022.
- Over 5 years, Revenue stood at $123.0 million in 2021, then tumbled by 49.17% to $62.5 million in 2022, then declined by 7.75% to $57.7 million in 2023, then dropped by 7.19% to $53.5 million in 2024, then soared by 185.88% to $153.0 million in 2025.
- According to Business Quant data, Revenue over the past three periods registered $153.0 million, $48.5 million, and $52.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Canopy Growth | 434.97 Mn | 187.96 Mn | 16.08 Mn | 72.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 72.56 Mn |
| Dec 31, 2025 | 153.00 Mn |
| Sep 30, 2025 | 48.45 Mn |
| Jun 30, 2025 | 52.06 Mn |
| Dec 31, 2024 | 53.52 Mn |
| Sep 30, 2024 | 46.18 Mn |
| Jun 30, 2024 | 48.41 Mn |
| Mar 31, 2024 | 54.02 Mn |
| Dec 31, 2023 | 57.66 Mn |
| Sep 30, 2023 | 51.91 Mn |
| Jun 30, 2023 | 56.77 Mn |
| Mar 31, 2023 | 85.98 Mn |
| Dec 31, 2022 | 62.51 Mn |
| Sep 30, 2022 | 67.43 Mn |
| Jun 30, 2022 | 93.08 Mn |
| Mar 31, 2022 | -273.68 Mn |
| Dec 31, 2021 | 122.99 Mn |
| Sep 30, 2021 | 104.36 Mn |
| Jun 30, 2021 | 110.81 Mn |
| Mar 31, 2021 | 117.28 Mn |